Letter: Should We Intensify Infliximab in Acute Severe Ulcerative Colitis?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15520
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Has Infliximab Influenced the Course and Prognosis of Acute Severe Ulcerative Colitis?

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2019English

Reply to Letter to the Editor: Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Inpatient Management of Acute Severe Ulcerative Colitis

Journal of Hospital Medicine
Internal MedicineCare PlanningHealth PolicyFundamentalsSkillsLeadershipManagementDiagnosisMedicineAssessment
2019English

Infliximab for IPILIMUMAB-Related Colitis--Letter

Clinical Cancer Research
Cancer ResearchOncology
2015English

Letter: How to Define Remission in Ulcerative Colitis - Histological Remission Should Be Considered

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Acute Colitis and Ulcerative Colitis

BMJ
1907English

PWE-237 Ciclosporin in Acute Severe Ulcerative Colitis: A Meta-Analysis

Gut
Gastroenterology
2012English

PTH-096 Oral Ciclopsorin in Steroid Refractory, Acute, Severe Ulcerative Colitis

Gut
Gastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy